留学主题咨询
￥420
芝士圈微信群成员首单优惠价
￥399 加入芝士圈微信群>>
微信扫码发送「咨询群优惠」进群
美英澳-硕士-卫生经济学/药物经济学-择校
其他 药物经济学 Health Economic and Outcome Research Health Technology Assessment 卫生经济学‘- 课程简述: 美英澳卫生经济学/药物经济学硕士项目申请推荐
- 适用用户: 想要攻读美英澳学校卫生经济学/药物经济学专业硕士研究生的同学
￥140
芝士圈微信群成员首单优惠价
￥133 加入芝士圈微信群>>
微信扫码发送「咨询群优惠」进群
美英澳-硕士-卫生经济学/药物经济学-专业咨询
其他 药物经济学 卫生经济学 Health Economic and Outcome Research Health Technology Assessment- 课程简述: 美英澳卫生经济学/药物经济学硕士项目咨询
- 适用用户: 想要攻读美英澳学校卫生经济学/药物经济学专业硕士研究生的同学
自我介绍
自我介绍
研究经历涵盖了医疗大数据/真实数据分析, 药物经济学, 卫生健康技术评估, 药物流行病学, 机器学习, 生物信息学.
Experienced in Big medical data/Real World Evidence, Pharmacoeconomics, Health Technology Assessment (HTA), Pharmacoepidemiology, Machine learning, Bioinformatic.
教育经历
教育
教育
The University of Hong Kong
PH.D Pharmacoeconomics and Pharmacoepidemiology
~
Johns Hopkins University
Master Health Economic and Outcome Research
~
Shenyang Pharmaceutical University
Bachelor Pharmacy
~
经历
经历
Research Assistant
The University of Hong Kong
~
- Using Markov-model to assess the cost-effectiveness of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in Hong Kong.
- Using IQVIA-MIDAS sales audit data, conducted an interrupted time series analysis to explore the impact of biosimilars on the sales volumes and price of their reference biologics.
- Assisted (Data collection, manipulation, and statistical analysis) a retrospective case-control study to investigate the association between the covid-19 vaccination and occurrence of carditis in Hong Kong.
- Assisted (Data collection, manipulation, and statistical analysis) a prospective cohort study to compare the self-reported adverse reaction following the use of two types of covid-19 vaccine in Hong Kong.
- Designed and distributed a questionnaire to understand the barriers of using biologic/targeted synthetic disease-modifying antirheumatic drugs (DMARDs) among patients with autoimmune diseases in Hong Kong.
- Conducted a systematic review on the cost-effectiveness of biologic/targeted synthetic DMARDs in treating autoimmune diseases
获奖 & 荣誉
发表文章
发表文章Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis
Peng, Kuan & Blais, Joseph & Pratt, Nicole & Guo, Jeff & Hillen, Jodie & Stanford, Tyman & Ward, Michael & Lai, Edward Chia-Cheng & Shin, Ju-Young & Tong, Xinning & Fan, Min & Cheng, Franco & Wu, Jing & Yeung, Winnie
BioDrugs
Cost-Effectiveness of Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Hong Kong
Peng, Kuan & Li, Yihua & Chan, Esther & Wong, Ian & Li, Xue
Value in Health Regional Issue
Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac)
Li, Xue & Peng, Kuan & Cheng, Franco & Lam, David & Cheung, Ching-Lung & Chui, Celine & Lai, Francisco & Wan, Eric
Journal of Infection
Post-Covid-19-vaccination adverse events and healthcare utilization among individuals with or without previous SARS-CoV-2 infection
Lai, Francisco & Huang, Lei & Peng, Kuan & Li, Xue & Chui, Celine & Wan, Eric Yuk Fai & Wong, Carlos & Chan, Esther & Hung, Ivan & Wong, Ian
Journal of Internal Medicine
Two-dose Covid-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong
Xue Li, #, Xinning Tong, #, Winnie Wan Yin Yeung, Kuan Peng, Celine SL Chui, Francisco Lai, Eric Wan, Carlos Wong, Esther Chan, Chak-Sing Lau, Ian Chi Kei Wong*
Annals of the Rheumatic Diseases
Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine: A Case-Control Study
Lai, Francisco & Li, Xue & Peng, Kuan & Huang, Lei & Ip, Patrick & Tong, Xinning & Chui, Celine & Wan, Eric Yuk Fai & Wong, Carlos & Chan, Esther & Siu, David & Wong, Ian
Annals of Internal Medicine
服务评价
- 还没有收到过评论
苏公网安备 32011302320939号